SPYRAL DYSTAL Renal Denervation Global Clinical Study
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Andrew Sharp, MD
University Hospital of Wales
Principal Investigator - David P Lee, MD
Stanford University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Universitaetsklinikum Erlangen
Erlangen, Germany
- Universitaetsklinikum Des Saarlandes
Homburg, Germany
- Herzzentrum Leipzig
Leipzig, Germany
- Hippokration General Hospital of Athens
Athens, Greece
- University Hospital of Wales
Cardiff, United Kingdom
- Stanford Hospital and Clinics
Stanford, California, United States
- Piedmont Heart Institute
Atlanta, Georgia, United States
- Baylor Heart & Vascular Hospital
Dallas, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 12 Jun 2020
- Primary completion
- 22 Dec 2022
- Completion
- 22 Dec 2022
- Last update posted
- 17 Apr 2024
- Registered enrollment
- 128
- Registry id
- NCT04311086
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.